Daihan Pharmaceutical Co.,Ltd. (KOSDAQ:023910)
30,700
+400 (1.32%)
At close: Oct 2, 2025
Daihan Pharmaceutical Market Cap
Daihan Pharmaceutical has a market cap or net worth of 176.40 billion as of October 10, 2025. Its market cap has increased by 16.73% in one year.
Market Cap
176.40B
Enterprise Value
77.79B
Revenue
207.68B
Ranking
n/a
PE Ratio
5.63
Stock Price
30,700.00
Market Cap Chart
Since March 1, 2001, Daihan Pharmaceutical's market cap has increased from 22.26B to 176.40B, an increase of 692.45%. That is a compound annual growth rate of 8.77%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 10, 2025 | 176.40B | 14.50% |
Dec 30, 2024 | 154.06B | -5.59% |
Dec 28, 2023 | 163.17B | -11.13% |
Dec 29, 2022 | 183.60B | 6.62% |
Dec 30, 2021 | 172.20B | -12.90% |
Dec 30, 2020 | 197.70B | 4.11% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Electronics | 579.68T |
SK hynix | 273.06T |
LG Energy Solution | 93.37T |
Samsung Biologics | 71.81T |
Hanwha Aerospace | 56.44T |
Hyundai Motor Company | 48.05T |
HD Hyundai Heavy Industries | 46.87T |
KB Financial Group | 42.53T |